Cancer Molecular Diagnostics, St. James's Hospital, Dublin, Ireland.
Int J Lab Hematol. 2012 Aug;34(4):417-21. doi: 10.1111/j.1751-553X.2012.01402.x. Epub 2012 Feb 7.
Hairy cell leukaemia (HCL) has distinct clinical, morphological and immunophenotypic features with no recurrent cytogenetic or molecular abnormalities reported until the recent description of the BRAF V600E mutation in patients with classical HCL. The incidence of this mutation was sought in 27 patients with either classical HCL or HCL variant by an allele-specific PCR approach and findings related to morphology, cytochemistry and immunophenotype. A high degree of correlation was noted between the presence of BRAF V600E and established diagnostic criteria in 26/27 patients with HCL/HCL variant. Detection of the BRAF V600E mutation is therefore a useful adjunct in the differential diagnosis of HCL and HCL variant and highlights the value of a multifaceted approach to the diagnosis of this malignancy.
毛细胞白血病(HCL)具有独特的临床、形态学和免疫表型特征,直到最近才在经典 HCL 患者中发现 BRAF V600E 突变,在此之前并未报道其存在复发的细胞遗传学或分子异常。本研究采用等位基因特异性 PCR 方法,对 27 例经典 HCL 或 HCL 变异患者进行 BRAF V600E 突变检测,并分析其与形态学、细胞化学和免疫表型的关系。结果发现,26/27 例 HCL/HCL 变异患者的 BRAF V600E 检测结果与既定的诊断标准具有高度相关性。因此,BRAF V600E 突变的检测可作为 HCL 和 HCL 变异的鉴别诊断的有用辅助手段,突显了对这种恶性肿瘤采用多方面诊断方法的重要性。